Literature DB >> 19597332

The Akt kinases: isoform specificity in metabolism and cancer.

Eva Gonzalez1, Timothy E McGraw.   

Abstract

The Akt (PKB) protein kinases are critical regulators of human physiology that control an impressive array of diverse cellular functions, including the modulation of growth, survival, proliferation and metabolism. The Akt kinase family is comprised of three highly homologous isoforms: Akt1 (PKBalpha), Akt2 (PKBbeta) and Akt3 (PKBgamma). Phenotypic analyses of Akt isoform knockout mice documented Akt isoform specific functions in the regulation of cellular growth, glucose homeostasis and neuronal development. Those studies establish that the functions of the different Akt kinases are not completely overlapping and that isoform-specific signaling contributes to the diversity of Akt activities. However, despite these important advances, a thorough understanding about the specific roles of Akt family members and the molecular mechanisms that determine Akt isoform functional specificity will be essential to elucidate the complexity of Akt regulated cellular processes and how Akt isoform-specific deregulation might contribute to disease states. Here, we summarize recent advances in understanding the roles of Akt isoforms in the regulation of metabolism and cancer, and possible mechanisms contributing to Akt isoform functional specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597332      PMCID: PMC2997486          DOI: 10.4161/cc.8.16.9335

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  80 in total

1.  ClipR-59 interacts with Akt and regulates Akt cellular compartmentalization.

Authors:  Jixin Ding; Keyong Du
Journal:  Mol Cell Biol       Date:  2009-01-12       Impact factor: 4.272

2.  The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development.

Authors:  Annette Schenck; Livia Goto-Silva; Claudio Collinet; Muriel Rhinn; Angelika Giner; Bianca Habermann; Michael Brand; Marino Zerial
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

3.  The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation.

Authors:  Tsugumichi Saito; Christine C Jones; Shaohui Huang; Michael P Czech; Paul F Pilch
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

4.  Muscle cells engage Rab8A and myosin Vb in insulin-dependent GLUT4 translocation.

Authors:  Shuhei Ishikura; Amira Klip
Journal:  Am J Physiol Cell Physiol       Date:  2008-08-13       Impact factor: 4.249

Review 5.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

6.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival.

Authors:  Jessica A Wofford; Heather L Wieman; Sarah R Jacobs; Yuxing Zhao; Jeffrey C Rathmell
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

Review 7.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

8.  A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.

Authors:  John D Carpten; Andrew L Faber; Candice Horn; Gregory P Donoho; Stephen L Briggs; Christiane M Robbins; Galen Hostetter; Sophie Boguslawski; Tracy Y Moses; Stephanie Savage; Mark Uhlik; Aimin Lin; Jian Du; Yue-Wei Qian; Douglas J Zeckner; Greg Tucker-Kellogg; Jeffrey Touchman; Ketan Patel; Spyro Mousses; Michael Bittner; Richard Schevitz; Mei-Huei T Lai; Kerry L Blanchard; James E Thomas
Journal:  Nature       Date:  2007-07-04       Impact factor: 69.504

9.  A novel AKT3 mutation in melanoma tumours and cell lines.

Authors:  M A Davies; K Stemke-Hale; C Tellez; T L Calderone; W Deng; V G Prieto; A J F Lazar; J E Gershenwald; G B Mills
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

10.  Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.

Authors:  Jeffrey A Engelman; Liang Chen; Xiaohong Tan; Katherine Crosby; Alexander R Guimaraes; Rabi Upadhyay; Michel Maira; Kate McNamara; Samanthi A Perera; Youngchul Song; Lucian R Chirieac; Ramneet Kaur; Angela Lightbown; Jessica Simendinger; Timothy Li; Robert F Padera; Carlos García-Echeverría; Ralph Weissleder; Umar Mahmood; Lewis C Cantley; Kwok-Kin Wong
Journal:  Nat Med       Date:  2008-11-30       Impact factor: 53.440

View more
  208 in total

Review 1.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Identification of a potent activator of Akt phosphorylation from a novel series of phenolic, picolinic, pyridino, and hydroxamic zinc(II) complexes.

Authors:  Savvas N Georgiades; Lok Hang Mak; Inmaculada Angurell; Evelyn Rosivatz; M Firouz Mohd Mustapa; Christoulla Polychroni; Rudiger Woscholski; Ramon Vilar
Journal:  J Biol Inorg Chem       Date:  2010-10-23       Impact factor: 3.358

Review 3.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

4.  Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression.

Authors:  Nicole K Speed; Heinrich J G Matthies; J Phillip Kennedy; Roxanne A Vaughan; Jonathan A Javitch; Scott J Russo; Craig W Lindsley; Kevin Niswender; Aurelio Galli
Journal:  ACS Chem Neurosci       Date:  2010-05-25       Impact factor: 4.418

5.  Phosphorylation-dependent substrate selectivity of protein kinase B (AKT1).

Authors:  Nileeka Balasuriya; Norman E Davey; Jared L Johnson; Huadong Liu; Kyle K Biggar; Lewis C Cantley; Shawn Shun-Cheng Li; Patrick O'Donoghue
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 6.  Insulin regulation of gluconeogenesis.

Authors:  Maximilian Hatting; Clint D J Tavares; Kfir Sharabi; Amy K Rines; Pere Puigserver
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

7.  The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.

Authors:  Tina Hörbelt; Christopher Tacke; Mariya Markova; Daniella Herzfeld de Wiza; Frederique Van de Velde; Marlies Bekaert; Yves Van Nieuwenhove; Silke Hornemann; Maria Rödiger; Nicole Seebeck; Elisabeth Friedl; Wenke Jonas; G Hege Thoresen; Oliver Kuss; Anke Rosenthal; Volker Lange; Andreas F H Pfeiffer; Annette Schürmann; Bruno Lapauw; Natalia Rudovich; Olga Pivovarova; D Margriet Ouwens
Journal:  Diabetologia       Date:  2018-05-12       Impact factor: 10.122

8.  Fine-tuning AKT kinase activity through direct lysine methylation.

Authors:  Jianping Guo; Wenyi Wei
Journal:  Cell Cycle       Date:  2019-05-03       Impact factor: 4.534

Review 9.  Role of AKT signaling in DNA repair and clinical response to cancer therapy.

Authors:  Qun Liu; Kristen M Turner; W K Alfred Yung; Kexin Chen; Wei Zhang
Journal:  Neuro Oncol       Date:  2014-05-07       Impact factor: 12.300

10.  Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1.

Authors:  Nitin K Agarwal; Changju Qu; Kranthi Kunkalla; Kranthi Kunkulla; Yadong Liu; Francisco Vega
Journal:  J Biol Chem       Date:  2013-04-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.